Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Pablo J. Cagnoni currently holds 240,848 shares of Rubius Therapeutics, Inc. (RUBY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pablo J. Cagnoni has been a net seller of RUBY stock. They have purchased $98.7K and sold $1.9M worth of shares.
Pablo J. Cagnoni's most recent insider trade was on Jun 1, 2026, when they sold 25,469 shares at $95.59 per share.
Pablo J. Cagnoni serves as Executive at Rubius Therapeutics, Inc. (RUBY). They have executed 44 insider transactions totaling $2.0M over their tenure at the company.
Pablo J. Cagnoni holds the position of Executive at Rubius Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Pablo J. Cagnoni has shown a selling trading pattern, with $98.7K in total purchases and $1.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Pablo J. Cagnoni was on Jun 1, 2026, when they sold $2.4M worth of INCY shares. This transaction involved 25,469 shares at $95.59 per share.
Pablo J. Cagnoni currently owns 240,848 shares of Rubius Therapeutics, Inc. (RUBY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Pablo J. Cagnoni's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Pablo J. Cagnoni has 44 Form 4 filings on record as an insider at Rubius Therapeutics, Inc..
Set alerts for Pablo J. Cagnoni and 40,000+ other insiders.